Company news

Share this article:
Roche was ordered to pay $12,895,500 to three plaintiffs claiming the drugmaker's acne medication, Accutane, caused inflammatory bowel disease that resulted in permanent injuries. The case was heard in a New Jersey Superior Court, and then transferred to an Accutane mass tort case in New Jersey's Atlantic County.
 
WellDoc Communications (a technology solutions company focused on chronic disease management) and dLife (a diabetes multimedia network) have announced a partnership. The partnership combines WellDoc's web- and moble-based diabetes management tools with dLife's online patient support tools.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.